RAS activation via CRLF2 signaling is a widespread mechanism in Down syndrome acute lymphoblastic leukemia regardless of RAS mutations
暂无分享,去创建一个
D. Nižetić | G. Basso | A. Yeoh | H. Ariffin | D. Weinstock | Debleena Ray | W. Chng | David Koschut | Zhenhua Li | Emanuela Giarin | J. Groet | I. Alić | S. Kham